Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70(s6K) pathway in human pancreatic cancer cells

Cancer Research

Volumn 59, Issue 15, 1999, Pages 3581-3587

  Grewe, Martin ^a   Gansauge, Frank ^a   Schmid, Roland M ^a   Adler, Guido ^a   Seufferlein, Thomas ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOMA; CELL CYCLE; CELL CYCLE PROTEINS; CULTURE MEDIA, SERUM-FREE; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; SIROLIMUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033178702     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Todd, K. E., and Reber, H. A. Pancreatic neoplasms. Curr. Opin. Gastroenterol., 12: 436-441, 1996.
2. Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, H., Büchler, M., and Beger, H. G. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor α. J. Clin. Investig., 50: 1352-1360, 1992.
3. s6k. Crit. Rev. Biochem. Mol. Biol., 29: 385-413, 1994.
4. Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Shin, T. B., and Schreber, S. L. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature (Lond.), 377: 441-446, 1995.
5. Price, D. J., Grove, J. R., Calvo, V., Avruch, J., and Bierer, B. E. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science (Washington DC), 257: 973-977, 1992.
6. s6k pathway and is independent of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA, 93: 4076-4080, 1996.
7. Chou, M. M., and Blenis, J. The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr. Opin. Cell Biol., 7: 806-814, 1995.
8. Francavilla, A., Carr, B. I., Starzl, T. E., Azzarone, A., Carrieri, G., and Zeng, Q. H. Effects of rapamycin on cultured hepatocyte proliferation and gene expression. Hepatology, 15: 871-877, 1992.
9. Marx, S. O., Jayaraman, T., Go, L. O., and Marks, A. R. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ. Res., 76: 412-417, 1995.
10. s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells. Cancer Res., 56: 3895-3897, 1996.
11. S6k. EMBO J., 16: 3693-3704, 1997.
12. Sonenberg, N., and Gingras, A. C. The mRNA 5′cap-binding protein eIF4E and control of cell growth. Curr. Opin. Cell Biol., 10: 268-275, 1998.
13. Rousseau, D., Gingras, A. C., Pause, A., and Sonenberg, N. The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene, 13: 2415-2420, 1996.
14. Hara, K., Yonezawa, K., Kozlowski, M. T., Sugimoto, T., Andrabi, K., Weng, Q. P., Kasuga, M., Nishimoto, I., and Avruch, J. Regulation of eIF-4EBP1 phosphorylation by mTOR. J. Biol. Chem., 272: 26457-26463, 1997.
15. Kawasome, H., Papst, P., Webb, S., Keller, G. M., Johnson, G. L., Gelfand, E. W., and Terada, N. Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. Proc. Natl. Acad. Sci. USA, 95: 5033-5038, 1998.
16. Gingras, A-C., Svitkin, Y., Belsham, G., Pause, A., and Sonenberg, N. Activation of the translational suppressor 4E-BP1 following infection with encephalomyocarditis virus and poliovirus. Proc. Natl. Acad. Sci. USA, 93: 5578-5583, 1996.
17. Lin, T. A., Kong, X. M., Saltiel, A. R., Blackshear, P. J., and Lawrence, J. C. Control of PHAS-I by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway. J. Biol. Chem., 270: 18531-18538, 1995.
18. Hosoi, H., Dilling, M. B., Shikata, T., Liu, L. N., Shu, L., Ashmun, R. A., Germain, G. S., Abraham, R. T., and Houghton, P. J. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. Cancer Res., 59: 886-894, 1999.
19. Carney, D. N., Gazdar, A. F., and Minna, J. D. Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small cell carcinoma of the lung. Cancer Res., 40: 1820-1823, 1980.
20. Kip1) of cyclin-dependent kinase 4 activation. Cell, 79: 487-496, 1994.
21. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (Lond.), 372: 570-573, 1994.
22. S6k activation from DNA synthesis stimulated by bombesin and insulin in Swiss 3T3 cells. J. Biol. Chem., 272: 2509-2514, 1997.
23. Shima, H., Pende, M., Chen, Y., Fumagalli, S., Thomas, G., and Kozma, S. C. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional kinase. EMBO J., 17: 6649-6659, 1998.
24. S6k-independent signaling in growth factor-stimulated NIH 3T3 cells. Mol. Cell. Biol., 19: 1569-1581, 1999.
25. 1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J. Biol, Chem., 273: 14424-14429, 1998.
26. Hunter, T., and Pines, J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
27. Weinstein, I. B. Relevance of cyclin D1 and other molecular markers to cancer chemoprevention. J. Cell. Biochem., 25: 23-28, 1996.
28. Gansauge, S., Gansauge, F., Ramadani, M., Stoibbe, H., Rau, B., Harada, N., and Beger, H. G. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res., 57: 1634-1637, 1997.
29. Kornmann, M., Arber, N., and Korc, M. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J. Clin. Investig., 101: 344-352, 1998.